Grab your favorite coffee. This is where you’ll find all the substance you require, and more.

Cognivia-Narrow-Hero-1
News

Introducing Cognivia Signal: Real-Time Behavioral Risk Intelligence for Clinical Trials

Cognivia launches the world’s first real-time behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia, the AI-driven leader in behavioral science for clinical research, proudly announces the launch of Cognivia Signal, a groundbreaking solution…

Read More
Insights

Disruptive Technology Without the Disruption

Implementing an innovative technology within a clinical trial is about much, much more than the technology – and while the tech might be “disruptive,” its actual implementation…

Read More
Insights

A “Unik” Approach to Capturing and Managing Patient Data

How the drive to maximize valuable data while minimizing patient and study team burden resulted in a unique data collection and management platform. Patient engagement is a…

Read More
Publication

Predicting Patient Drop-Out in Clinical Trials: A First Step Toward Personalized Engagement Strategies

Objective: Patient non-adherence and drop-out significantly extend the duration and cost of clinical trials. A predictive tool identifying…

Type: Scientific Poster
Authors: Samuel Branders, PhD Arthur Ooghe Alvaro Pereira, PhD Dominique Demolle, PhD
Conference: CNS Summit
Read More
Insights

A New Era of Cognivia

Innovation, evolution and agility have always been core elements of drug and device development. How else, but through creative, out-of-the-box thinking and a willingness to innovate have…

Read More
Insights

Innovation with Integrity

It has taken a decade of scientific integrity and rigor – and a very particular mindset – for Cognivia to develop its current suite of innovative solutions….

Read More
Publication

Prediction of the response to repetitive transcranial magnetic stimulation of the motor cortex in peripheral neuropathic pain and validation of a new algorithm

Abstract: Motor cortex repetitive transcranial magnetic stimulation (M1-rTMS) induces analgesic effects in neuropathic pain, but not all patients…

Type: Scientific Publication
Authors: Attal Nadine; Branders Samuel; Pereira Alvaro; Bouhassira Didier
Conference: The Journal of the International Association for the Study of Pain
Read More

Understand patient differences in your next clinical trial

Increase your trial’s success rates and bring new therapies to patients faster.

Tell us about your clinical trial below, and our team will be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.